Page last updated: 2024-10-22

albendazole and Gaucher Disease

albendazole has been researched along with Gaucher Disease in 1 studies

Gaucher Disease: An autosomal recessive disorder caused by a deficiency of acid beta-glucosidase (GLUCOSYLCERAMIDASE) leading to intralysosomal accumulation of glycosylceramide mainly in cells of the MONONUCLEAR PHAGOCYTE SYSTEM. The characteristic Gaucher cells, glycosphingolipid-filled HISTIOCYTES, displace normal cells in BONE MARROW and visceral organs causing skeletal deterioration, hepatosplenomegaly, and organ dysfunction. There are several subtypes based on the presence and severity of neurological involvement.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yuen, T1
Iqbal, J1
Zhu, LL1
Sun, L1
Lin, A1
Zhao, H1
Liu, J1
Mistry, PK1
Zaidi, M1

Other Studies

1 other study available for albendazole and Gaucher Disease

ArticleYear
Disease-drug pairs revealed by computational genomic connectivity mapping on GBA1 deficient, Gaucher disease mice.
    Biochemical and biophysical research communications, 2012, Jun-15, Volume: 422, Issue:4

    Topics: Albendazole; Animals; Anthelmintics; Computational Biology; Disease Models, Animal; Drug Discovery;

2012